INNV Financials 07/15/2014 20:10:40
Innovus Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 7 - - -
Cost of Revenue 2 - - -
Gross Profit 5 - - -
Operating Expenses
Research and Development 93 2 59 -
Sales, General and Admin. 3,801 217 2,130 54
Non-Recurring Items - - - -
Other - - - -
Operating Income (3,889) (219) (2,189) (54)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (3,889) (219) (2,189) (54)
Interest Expense 67 17 68 16
Earnings Before Tax (3,956) (237) (2,256) (70)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,956) (237) (2,256) (70)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,956) (237) (2,256) (70)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,956) (237) (2,256) (70)